Drug & medication recalls Moderate risk

B-COMPLEX 50 IN NACL 0 recalled over sterility concerns

Recall date
May 13, 2016
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Medaus, Inc. recalls B-COMPLEX 50 IN NACL 0.9% W/PRES., (BENZYL ETOH 2%), B1-50MG, B2-5-PO4-5MG, B3-50MG, B5-50MG, B6-50MG/ML, 10ML Vials, M…
Recall number
D-1173-2016
FDA classification
Class II
Brand / firm
Medaus, Inc.
Sold / distributed
U.S. Nationwide, Japan, and New Zealand.

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

B-COMPLEX 50 IN NACL 0.9% W/PRES., (BENZYL ETOH 2%), B1-50MG, B2-5-PO4-5MG, B3-50MG, B5-50MG, B6-50MG/ML, 10ML Vials, MEDAUS PHARMACY

Get recall alerts

Free email alert whenever Medaus, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Medaus, Inc.